Alec Hogg’s Inbox: Ivermectin in the spotlight once more
The cheap generic drug which many believe helps fight the coronavirus is once more in the spotlight, with this note opening a new avenue of inquiry for the open minded.
The cheap generic drug which many believe helps fight the coronavirus is once more in the spotlight, with this note opening a new avenue of inquiry for the open minded.
From the get go, we’ve put our faith in medical professionals and big pharma to seek help and guidance through this pandemic.
South Africa’s Constitutional Court cleared President Cyril Ramaphosa of allegations that he misled lawmakers over campaign-finance donations.
“Meta-analysis by the American Journal of Therapeutics of 60 studies has given a big thumbs up to Ivermectin as a shield against COVID,” says Alec Hogg.
Rebecca Giersiefen looks at ivermectin as a Covid treatment, asking why so many institutions haven’t authorised its use – despite evidence of its efficacy.
A large UK study at the University of Oxford is to investigate the use of Ivermectin, as a possible treatment for Covid-19, reports Bloomberg.
“We hope to generate robust evidence to determine how effective ivermectin is against Covid-19”, said a professor of medicine at the University of Oxford.
To the rational mind, official messages propagated around Covid-19 have more holes than a good Emmentaler.
William Saunderson-Meyer is well-known in the medical community. He gives his views on the proposed National Health Insurance and touches on Ivermectin.
Ivermectin is seen as a repeat of hydroxychloroquine and not to be taken seriously. Belief in it, worthy only of derision, writes Andrew Bannister.